Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot Study

NCT04899687 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04899687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04899687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot Study
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Recruiting
Start date
January 20, 2022
Completion date
December 1, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body dysmorphic disorders, illness anxiety disorder, obsessive-compulsive disorder, somatic symptom disorder